Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Gross margin
€ 196,870
▲ 181% vs 2024
Profit
Caution€ -36,329
▲ 69% vs 2024
Debts
Low€ 173,439
▼ 52% vs 2024
XeroThera Europe from Liège, company number BE0697932717, closed financial year 2025 with a result of € -36,329 after tax. For that financial year XeroThera Europe recorded a gross margin of € 196,870 and equity of € 646,920. Compared with financial year 2024, the result moved from € -117,261 to € -36,329. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 14, 2026.
What happened at XeroThera Europe?
What happened at XeroThera Europe in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 36,329. filed late Source: NBB ↗
- New establishment in Liège. KBO
- PAUL DUCHEYNE became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 2,537 loss in 2021 to € 36,329 loss in 2025.
On average € 98,400 of value added per employee in 2025.
A new publication or filing at XeroThera Europe? We notify you, reason included.
Follow XeroThera EuropeNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind XeroThera Europe is PAUL DUCHEYNE.
Directors
According to the 2025 annual accounts
PAUL DUCHEYNE
Director
since 2018
Establishments
Establishment units
Physical locations of this company
Avenue Hippocrate 5
4000 Liège
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
Sagitta Biotech
€ -138,661 gross margin · 2025
QUIDDITAS
€ 175,986 gross margin · 2025
ARTIALIS
€ 320,267 gross margin · 2024
Temple OrthoBiologics
€ -225,322 gross margin · 2025
BRENUS PHARMA BELGIUM
+1 more
Details
- Company number
- 0697.932.717
- VAT number
- BE 0697.932.717
- Registered office
- Avenue Hippocrate 5, 4000 Liège
- Names & denominations
- XeroThera Europe
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 June 2018
- Peppol
- Active · Active since 10 Dec 2025
- Activities · NACE
Vervaardiging van farmaceutische grondstoffen
Speur- en ontwikkelingswerk op biotechnologisch gebied
Vervaardiging van overige farmaceutische producten